Healthy volunteers help test new myelofibrosis drug absorption
NCT ID NCT07492355
First seen Mar 31, 2026 · Last updated May 22, 2026 · Updated 9 times
Summary
This study tested two different capsule forms of the drug TP-3654 in 24 healthy adults to see how well the body absorbs them and whether taking them with food changes absorption. The goal is to find the best capsule and dosing conditions for future studies in people with myelofibrosis. Participants were generally healthy and took the drug under fasting or fed conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOFIBROSES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Frontage Clinical
Secaucus, New Jersey, 07094, United States
Conditions
Explore the condition pages connected to this study.